Iopamidol Injection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and listed Iopamidol Injection, one of the most widely used types of contrast medium in the Chinese market.
Product name: Iopamidol Injectionnon
Generic name: Iopamidol Injection
Type: Injectable Contrast Media for CT/X-ray
(1) 50ml: 15 gl
(2) 100ml: 30 gl
(3) 50ml: 18.5 gl
(4) 100ml: 37 gl
Administration: Intravascular injection
Adverse reactions: The application of organic iodine compounds can cause adverse reactions, as well as allergic or drug-induced shock. See the details from the package insert
Shelf life: 36 months
High enhancement value, which increased the contrast between the lesion and solid organs, improved the lesion detection.
Low osmotic pressure
Low injection speed, which reduces vascular pressure and prevents contrast media extravasation (patient with poor tolerance, such as children, elderly, diabetes or tumor patients, are more suitable for high-concentration contrast media)
The low total dosage of Contrast media
Low radiation dose
Neuroradiology: Spinal nerve root angiography, Cisternography and ventriculography.
Angiography: Cerebral arteriography, Coronary angiography, Thoracic aorta and abdominal aorta angiography, Angiocardiography, Selectivevisceral arteriography, Peripheral arteriography and venography, Digital subtraction angiography of cerebral arteries, peripheral arteries and abdominal arteries.
Urinary system angiography: Venous urography, Enhanced scan in CT examination, Arthrography, Fistula angiography, Digital subtraction angiography.
Precautions please refer to the package insert.